JOSEPH BARRY: Open Payments
NPI 1710950365 · CAMILLUS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$623 in 29 payments from 17 companies in 2025. Trend: 2023 $556 · 2024 $680 · 2025 $623
Food & beverage: $590Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $106 |
| Lilly USA, LLC | 4 | $67 |
| Astellas Pharma US Inc | 2 | $66 |
| ABBVIE INC. | 3 | $53 |
| Corcept Therapeutics | 2 | $51 |
| Boston Scientific Corporation | 2 | $34 |
| Antares Pharma, Inc. | 1 | $34 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Seqirus USA Inc | 1 | $23 |
Products named: MOUNJARO, Veozah, Korlym, QULIPTA, WATCHMAN FLX, XYOSTED, JOURNAVX, Ozempic.
Industry payments across NY — which companies pay providers there.
